{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T00:12:08Z","timestamp":1791850328616,"version":"4.3.4"},"reference-count":129,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2007,4,1]],"date-time":"2007-04-01T00:00:00Z","timestamp":1175385600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2007,4,1]],"date-time":"2007-04-01T00:00:00Z","timestamp":1175385600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["cghjournal.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Gastroenterology and Hepatology"],"published-print":{"date-parts":[[2007,4]]},"DOI":"10.1016\/j.cgh.2006.10.014","type":"journal-article","created":{"date-parts":[[2007,1,13]],"date-time":"2007-01-13T12:20:02Z","timestamp":1168690802000},"page":"408-416","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":61,"title":["Complementary and Alternative Medicine in Hepatology: Review of the Evidence of Efficacy"],"prefix":"10.1016","volume":"5","author":[{"given":"Sumita","family":"Verma","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul J.","family":"Thuluvath","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.cgh.2006.10.014_bib1","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1002\/hep.510300437","article-title":"Herbal products for liver disease: a therapeutic challenge for the new millennium","volume":"30","author":"Schuppan","year":"1999","journal-title":"Hepatology"},{"key":"10.1016\/j.cgh.2006.10.014_bib2","first-page":"49","article-title":"The U.S. botanical market\u2014an overview","volume":"36","author":"Breevort","year":"1996","journal-title":"Herbalgramm"},{"key":"10.1016\/j.cgh.2006.10.014_bib3","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1056\/NEJM199301283280406","article-title":"Unconventional medicine in the United States","volume":"328","author":"Eisenberg","year":"1993","journal-title":"N Engl J Med"},{"key":"10.1016\/j.cgh.2006.10.014_bib4","doi-asserted-by":"crossref","first-page":"1569","DOI":"10.1001\/jama.280.18.1569","article-title":"Trends in alternative medicine use in the United States, 1990-1997: results of a follow-up national survey","volume":"280","author":"Eisenberg","year":"1998","journal-title":"JAMA"},{"key":"10.1016\/j.cgh.2006.10.014_bib5","first-page":"2654","article-title":"The use of naturopathic remedies for chronic liver disease (letter)","volume":"91","author":"Flora","year":"1996","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.cgh.2006.10.014_bib6","first-page":"A478","article-title":"Comparison of herbal remedies for liver disease: 1996 versus 1999 (abstr)","author":"Berk","year":"1999","journal-title":"Hepatology"},{"key":"10.1016\/j.cgh.2006.10.014_bib7","first-page":"A123","article-title":"A survey of the use of herbal medicine in patients with hepatitis C (abstr)","volume":"30","author":"Peyton","year":"1999","journal-title":"Hepatology"},{"key":"10.1016\/j.cgh.2006.10.014_bib8","doi-asserted-by":"crossref","first-page":"2391","DOI":"10.1111\/j.1572-0241.2002.05993.x","article-title":"Use of complementary and alternative medicine in patients with liver disease","volume":"97","author":"Strader","year":"2002","journal-title":"Am J Gastroenterol"},{"issue":"Suppl 1","key":"10.1016\/j.cgh.2006.10.014_bib9","doi-asserted-by":"crossref","first-page":"A228","DOI":"10.1016\/S0016-5085(08)81132-8","article-title":"Herbal medicines consumption for chronic liver disease and functional intestinal disorders (abstr)","volume":"120","author":"Detkova","year":"2001","journal-title":"Gastroenterology"},{"issue":"Suppl 1","key":"10.1016\/j.cgh.2006.10.014_bib10","doi-asserted-by":"crossref","first-page":"A409","DOI":"10.1016\/S0016-5085(08)82032-X","article-title":"Complementary-alternative medicine (CAM) use amongst patients with chronic hepatitis C infection (HCV) (abstr)","volume":"120","author":"Russo","year":"2001","journal-title":"Gastroenterology"},{"key":"10.1016\/j.cgh.2006.10.014_bib11","doi-asserted-by":"crossref","first-page":"1553","DOI":"10.1001\/jama.280.18.1553","article-title":"Medical news and perspectives: alterations are ahead at the OAM","volume":"280","author":"Marwick","year":"1998","journal-title":"JAMA"},{"key":"10.1016\/j.cgh.2006.10.014_bib12","volume":"Volume 2","author":"Greive","year":"1981"},{"key":"10.1016\/j.cgh.2006.10.014_bib13","first-page":"442","article-title":"Silymarin: what is in the name\u2009\u2026\u2009?","volume":"32","author":"Simanek","year":"2000","journal-title":"Hepatology"},{"key":"10.1016\/j.cgh.2006.10.014_bib14","first-page":"272","article-title":"Monograph","volume":"4","year":"1999","journal-title":"Altern Med Rev"},{"key":"10.1016\/j.cgh.2006.10.014_bib15","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1111\/j.1572-0241.1998.00139.x","article-title":"Milk thistle for the therapy of liver disease","volume":"93","author":"Flora","year":"1998","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.cgh.2006.10.014_bib16","first-page":"655","article-title":"Meth find exp","volume":"6","author":"Lorenz","year":"1984","journal-title":"Clin Pharmacol"},{"key":"10.1016\/j.cgh.2006.10.014_bib17","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1007\/BF03190223","article-title":"Pharmokinetic studies in IdB 1016, a silybin-phosphatidylcholine complex, in healthy human subjects","volume":"15","author":"Barzaghi","year":"1990","journal-title":"Eur J Drug Metab Pharmacokinet"},{"key":"10.1016\/j.cgh.2006.10.014_bib18","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1055\/s-2008-1074867","article-title":"Studies on elimination of silymarin in cholecystectomized patients. I. Biliary and renal elimination after a single oral dose","volume":"38","author":"Flory","year":"1980","journal-title":"Planta Med"},{"key":"10.1016\/j.cgh.2006.10.014_bib19","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1002\/hep.510260215","article-title":"Oxygen-free radical-mediated injury to cultured rat hepatocytes during cold incubation in preservation solutions","volume":"26","author":"Rauen","year":"1997","journal-title":"Hepatology"},{"key":"10.1016\/j.cgh.2006.10.014_bib20","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1055\/s-2006-962055","article-title":"Silibinin dihemisuccinate protects against glutathione depletion and lipid peroxidation induced by acetaminophen in rat liver","volume":"55","author":"Campos","year":"1989","journal-title":"Planta Med"},{"key":"10.1016\/j.cgh.2006.10.014_bib21","doi-asserted-by":"crossref","first-page":"1941","DOI":"10.1016\/0016-5085(95)90762-9","article-title":"Antioxidant activity of silybin in vivo during long-term iron overload in rats","volume":"109","author":"Pietrangelo","year":"1995","journal-title":"Gastroenterology"},{"key":"10.1016\/j.cgh.2006.10.014_bib22","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1177\/096032718300200203","article-title":"Chemotherapy of Amanita phalloides poisoning with intravenous silibinin","volume":"2","author":"Hruby","year":"1983","journal-title":"Hum Toxicol"},{"key":"10.1016\/j.cgh.2006.10.014_bib23","first-page":"103","article-title":"Phytotherapeutic alternatives for chronic active hepatitis","volume":"summer","author":"Reichert","year":"1997","journal-title":"Q Rev Nat Med"},{"key":"10.1016\/j.cgh.2006.10.014_bib24","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1016\/0006-2952(94)90053-1","article-title":"Scavenging of reactive oxygen species by silibinin dihemisuccinate","volume":"48","author":"Mira","year":"1994","journal-title":"Biochem Pharmacol"},{"key":"10.1016\/j.cgh.2006.10.014_bib25","first-page":"1383","article-title":"Effects of silybinin and a synthetic analogue on isolated rat hepatic stellate cells and myofibroblasts","volume":"47","author":"Fuchs","year":"1997","journal-title":"Arzneimittelforschung"},{"key":"10.1016\/j.cgh.2006.10.014_bib26","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1002\/hep.510260316","article-title":"Silymarin retards collagen accumulation in early and advanced bilary fibrosis secondary to complete bile duct obliteration in rats","volume":"26","author":"Boigk","year":"1987","journal-title":"Hepatology"},{"issue":"Suppl","key":"10.1016\/j.cgh.2006.10.014_bib27","first-page":"A546","article-title":"Silymarin downregulates TIMP-I and collagen I mRNA in rats with secondary biliary cirrhosis (abstr)","volume":"28","author":"Jia","year":"1998","journal-title":"Hepatology"},{"key":"10.1016\/j.cgh.2006.10.014_bib28","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1002\/hep.510230415","article-title":"Inhibition of Kupffer cell functions as an explanation for the hepatoprotective properties of silibinin","volume":"23","author":"Dehmlow","year":"1996","journal-title":"Hepatology"},{"key":"10.1016\/j.cgh.2006.10.014_bib29","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1053\/jhep.2001.27445","article-title":"Complementary and alternative medicine in chronic liver disease","volume":"34","author":"Seeff","year":"2001","journal-title":"Hepatology"},{"key":"10.1016\/j.cgh.2006.10.014_bib30","first-page":"628","article-title":"Kontrollierte klinische Pruefung von Legalon","volume":"133","author":"Cavalieri","year":"1974","journal-title":"Gaz Med Ital"},{"key":"10.1016\/j.cgh.2006.10.014_bib31","first-page":"1060","article-title":"Zur wirkung von Silymarin bei der Behandlung der akuten Virushepatitis","volume":"73","author":"Magliulo","year":"1978","journal-title":"Med Klin"},{"key":"10.1016\/j.cgh.2006.10.014_bib32","first-page":"513","article-title":"Silymarin for the treatment of acute viral hepatitis? Report of a controlled trial","volume":"72","author":"Bode","year":"1977","journal-title":"Med Klin"},{"issue":"Suppl 3","key":"10.1016\/j.cgh.2006.10.014_bib33","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1007\/BF03042201","article-title":"A conservative triple antioxidant approach to the treatment of hepatitis C","volume":"15","author":"Berkson","year":"1999","journal-title":"Med Klin"},{"key":"10.1016\/j.cgh.2006.10.014_bib34","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1016\/j.dld.2004.06.015","article-title":"Randomised double-blinded trial evaluating silymarin for chronic hepatitis C in an Egyptian village: study description and 12-month results","volume":"36","author":"Tanamly","year":"2004","journal-title":"Dig Liver Dis"},{"key":"10.1016\/j.cgh.2006.10.014_bib35","first-page":"68","article-title":"Oral silymarin for chronic hepatitis C\u2014a retrospective analysis comparing three dose regimens","volume":"10","author":"Huber","year":"2005","journal-title":"Eur J Med Res"},{"key":"10.1016\/j.cgh.2006.10.014_bib36","doi-asserted-by":"crossref","first-page":"517","DOI":"10.3109\/00365528209182242","article-title":"Effect of silymarin on chemical functional and morphological alterations of the liver","volume":"17","author":"Salmi","year":"1982","journal-title":"Scand J Gastroenterol"},{"key":"10.1016\/j.cgh.2006.10.014_bib37","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/0168-8278(89)90083-4","article-title":"Randomised controlled trial of silymarin treatment in patients with cirrhosis of the liver","volume":"9","author":"Ferenci","year":"1989","journal-title":"J Hepatol"},{"key":"10.1016\/j.cgh.2006.10.014_bib38","first-page":"2723","article-title":"Liver-protective action of silymarin therapy in chronic alcoholic liver diseases","volume":"130","author":"Feher","year":"1989","journal-title":"Orv Hetil"},{"key":"10.1016\/j.cgh.2006.10.014_bib39","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1016\/S0168-8278(98)80285-7","article-title":"Effects of silymarin in alcoholic patients with cirrhosis of the liver: results of a controlled, double blind randomised and multicentre trial","volume":"28","author":"Pares","year":"1998","journal-title":"J Hepatol"},{"key":"10.1016\/j.cgh.2006.10.014_bib40","doi-asserted-by":"crossref","first-page":"2","DOI":"10.5414\/CPP40002","article-title":"Effects of silymarin MZ-80 on oxidative stress in patients with alcoholic cirrhosis","volume":"40","author":"Lucena","year":"2002","journal-title":"Int J Clin Pharmacol Ther"},{"key":"10.1016\/j.cgh.2006.10.014_bib41","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1053\/jhep.2000.18663","article-title":"Silymarin in the treatment of patients with primary biliary cirrhosis with a suboptimal response to ursodeoxycholic acid","volume":"32","author":"Angulo","year":"2000","journal-title":"Hepatology"},{"key":"10.1016\/j.cgh.2006.10.014_bib42","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/0041-008X(84)90087-5","article-title":"Protection by silybinin against Amanita phalloides intoxication in beagles","volume":"73","author":"Vogel","year":"1984","journal-title":"Toxicol Appl Pharmacol"},{"key":"10.1016\/j.cgh.2006.10.014_bib43","first-page":"1164","article-title":"Poisoning by the death cap fungus (Amanita phalloides): prognostic factors and therapeutic measures","volume":"112","author":"Floersheim","year":"1982","journal-title":"Schweiz Med Wochenschr"},{"key":"10.1016\/j.cgh.2006.10.014_bib44","first-page":"23","article-title":"Silybinin in the treatment of deathcap fungus poisoning","volume":"6","author":"Hruby","year":"1984","journal-title":"Forum (Genova)"},{"key":"10.1016\/j.cgh.2006.10.014_bib45","first-page":"115","article-title":"Silymarin in the protection against exogenous noxae","volume":"7","author":"Boari","year":"1981","journal-title":"Drugs Exp Clin Res"},{"key":"10.1016\/j.cgh.2006.10.014_bib46","first-page":"249","article-title":"Protective effect of Legalon in workers exposed to organic solvents","volume":"45","author":"Szilard","year":"1988","journal-title":"Acta Med Hung"},{"key":"10.1016\/j.cgh.2006.10.014_bib47","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1016\/S0011-393X(05)80184-5","article-title":"The effects of silymarin on plasma levels of malondialdehyde in patients receiving long-term treatment with psychotropic drugs","volume":"55","author":"Palasciano","year":"1994","journal-title":"Curr Ther Res"},{"key":"10.1016\/j.cgh.2006.10.014_bib48","first-page":"236","article-title":"Effetti terapeutici della silimarina nelle epatopatie croniche indotte da psicofarmaci","volume":"135","author":"Saba","year":"1976","journal-title":"Gaz Med Ital"},{"key":"10.1016\/j.cgh.2006.10.014_bib49","doi-asserted-by":"crossref","first-page":"2583","DOI":"10.1111\/j.1572-0241.2005.00262.x","article-title":"Milk thistle for alcoholic and\/or hepatitis B or C liver diseases\u2014a systematic Cochrane hepato-biliary group review with meta-analyses of randomized clinical trials","volume":"100","author":"Rambaldi","year":"2005","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.cgh.2006.10.014_bib50","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1016\/S1542-3565(04)00455-0","article-title":"Use of herbal supplements for chronic liver disease","volume":"2","author":"Levy","year":"2004","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.cgh.2006.10.014_bib51","doi-asserted-by":"crossref","first-page":"2080","DOI":"10.1016\/S0149-2918(00)87239-2","article-title":"Pharmacokinetics of intravenous glycyrrhizin after single and multiple doses in patients with chronic hepatitis C infection","volume":"21","author":"van Rossum","year":"1999","journal-title":"Clin Ther"},{"key":"10.1016\/j.cgh.2006.10.014_bib52","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1016\/S0140-6736(87)91014-2","article-title":"Mineralocorticoid activity of liquorice: 11-beta-hydroxysteroid dehydrogenase deficiency comes of age","volume":"2","author":"Stewart","year":"1987","journal-title":"Lancet"},{"key":"10.1016\/j.cgh.2006.10.014_bib53","first-page":"73","article-title":"Treatment of hepatitis with antiallergic drug, Stronger Neo-Minophagen C","volume":"13","author":"Yamamoto","year":"1958","journal-title":"Clin Med Pediatr"},{"key":"10.1016\/j.cgh.2006.10.014_bib54","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1006\/taap.1998.8586","article-title":"Oxidative stress as a mechanism of chronic cadmium-induced hepatotoxicity and renal toxicity and protection by antioxidants","volume":"154","author":"Shaikh","year":"1999","journal-title":"Toxicol Appl Pharmacol"},{"key":"10.1016\/j.cgh.2006.10.014_bib55","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1111\/j.1600-0676.1998.tb00147.x","article-title":"Inhibitory effect of glycyrrhizin on NF-kappa B binding activity in CCl4-plus ethanol-induced liver cirrhosis in rats","volume":"18","author":"Wang","year":"1998","journal-title":"Liver"},{"key":"10.1016\/j.cgh.2006.10.014_bib56","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1111\/j.1440-1746.1997.tb00416.x","article-title":"Effects of glycyrrhizin on immune-mediated cytotoxicity","volume":"12","author":"Yoshikawa","year":"1997","journal-title":"J Gastroenterol Hepatol"},{"key":"10.1016\/j.cgh.2006.10.014_bib57","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1111\/j.1348-0421.1982.tb00207.x","article-title":"Interferon induction by glycyrrhizin and glycyrrhetinic acid in mice","volume":"26","author":"Abe","year":"1982","journal-title":"Microbiol Immunol"},{"key":"10.1016\/j.cgh.2006.10.014_bib58","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1016\/S0168-8278(94)80108-8","article-title":"Effects of glycyrrhizin on hepatitis B surface antigen: a biochemical and morphological study","volume":"21","author":"Takahara","year":"1994","journal-title":"J Hepatol"},{"key":"10.1016\/j.cgh.2006.10.014_bib59","first-page":"423","article-title":"Effects of glycyrrhizin on biochemical tests in patients with chronic hepatitis","volume":"26","author":"Suzuki","year":"1983","journal-title":"Asian Med J"},{"key":"10.1016\/j.cgh.2006.10.014_bib60","first-page":"797","article-title":"Effect of large dose of SNMC on the liver histology of chronic active hepatitis","volume":"13","author":"Hino","year":"1986","journal-title":"Kan Tansui"},{"key":"10.1016\/j.cgh.2006.10.014_bib61","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1007\/BF02782862","article-title":"Glycyrrhizin withdrawal followed by human lymphoblastoid interferon in the treatment of chronic hepatitis B","volume":"26","author":"Hayashi","year":"1991","journal-title":"Gastroenterol Jpn"},{"key":"10.1016\/j.cgh.2006.10.014_bib62","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1016\/S1386-6346(02)00086-4","article-title":"Randomized clinical trial with two doses (100 and 40 ml) of Stronger Neo-Minophagen C in Chinese patients with chronic hepatitis B","volume":"24","author":"Zhang","year":"2002","journal-title":"Hepatol Res"},{"key":"10.1016\/j.cgh.2006.10.014_bib63","first-page":"1817","article-title":"Effectiveness of interferon, glycyrrhizin combination therapy in patients with chronic hepatitis C","volume":"52","author":"Abe","year":"1994","journal-title":"Nippon Rinsho"},{"key":"10.1016\/j.cgh.2006.10.014_bib64","doi-asserted-by":"crossref","first-page":"2432","DOI":"10.1016\/S0002-9270(01)02612-0","article-title":"Glycyrrhizin induced reduction of ALT in European patients with chronic hepatitis","volume":"96","author":"van Rossun","year":"2001","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.cgh.2006.10.014_bib65","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.1097\/00042737-199910000-00002","article-title":"Combined ursodeoxycholic acid and glycyrrhizin therapy for chronic hepatitis C virus infection: a randomised controlled trial in 170 patients","volume":"11","author":"Tsubota","year":"1999","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"10.1016\/j.cgh.2006.10.014_bib66","doi-asserted-by":"crossref","first-page":"1494","DOI":"10.1002\/(SICI)1097-0142(19970415)79:8<1494::AID-CNCR8>3.0.CO;2-B","article-title":"The long term efficacy of glycyrrhizin in chronic hepatitis C patients","volume":"79","author":"Arase","year":"1997","journal-title":"Cancer"},{"key":"10.1016\/j.cgh.2006.10.014_bib67","first-page":"226","article-title":"Initial experience with ribavirin plus glycyrrhizin in renal allograft recipients with chronic hepatitis C","volume":"23","author":"Anand","year":"2004","journal-title":"Indian J Gastroenterol"},{"key":"10.1016\/j.cgh.2006.10.014_bib68","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1248\/yakushi1947.110.6_407","article-title":"Suppression of lipid peroxidation by sho-saiko-to and its components in rat liver subcellular membranes","volume":"110","author":"Miyahara","year":"1990","journal-title":"Yakugaku Zasshi"},{"key":"10.1016\/j.cgh.2006.10.014_bib69","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1002\/hep.510290108","article-title":"Effects of sho-saiho-to, a Japanese herbal medicine, on hepatic fibrosis in rats","volume":"29","author":"Shimizu","year":"1999","journal-title":"Hepatology"},{"key":"10.1016\/j.cgh.2006.10.014_bib70","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1111\/j.1349-7006.1996.tb03155.x","article-title":"Cell death induced by baicalein in human hepatocellular carcinoma cells","volume":"87","author":"Matsuzaki","year":"1996","journal-title":"Jpn J Cancer Res"},{"key":"10.1016\/j.cgh.2006.10.014_bib71","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1142\/S0192415X91000193","article-title":"Effect of sho-saiko-to (xiao-chai-hu-tang) on HbeAg clearance in fourteen children with chronic hepatitis B virus infection and with sustained liver disease","volume":"19","author":"Tajiri","year":"1991","journal-title":"Am J Chin Med"},{"key":"10.1016\/j.cgh.2006.10.014_bib72","first-page":"161","article-title":"Effects of TJ-9 Sho-saiko-to (Kampo medicine) on interferon gamma and antibody production specific for hepatitis B virus antigen in patients with type B chronic hepatitis","volume":"39","author":"Kakumu","year":"1991","journal-title":"Int J Immunopharmacol"},{"key":"10.1016\/j.cgh.2006.10.014_bib73","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1007\/BF02774173","article-title":"A multicentre randomised controlled clinical trial of Shosaiko-to in chronic active hepatitis","volume":"24","author":"Hirayama","year":"1989","journal-title":"Gastroenterol Jpn"},{"key":"10.1016\/j.cgh.2006.10.014_bib74","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1002\/1097-0142(19950901)76:5<743::AID-CNCR2820760506>3.0.CO;2-V","article-title":"Prospective study of chemoprevention of hepatocellular carcinoma with sho-saiko-tu (TJ-9)","volume":"76","author":"Oka","year":"1995","journal-title":"Cancer"},{"key":"10.1016\/j.cgh.2006.10.014_bib75","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1016\/S1089-3261(05)70174-4","article-title":"Herbal and complementary and alternative medicine therapies for liver disease","volume":"5","author":"Cohen","year":"2001","journal-title":"Clin Liver Dis"},{"key":"10.1016\/j.cgh.2006.10.014_bib76","first-page":"389","article-title":"A possible mechanism of interstitial pneumonia during interferon therapy with sho-saiko-to","volume":"33","author":"Murakami","year":"1995","journal-title":"Nihon Kyobu Shikkan Gakkai Zasshi"},{"key":"10.1016\/j.cgh.2006.10.014_bib77","first-page":"703","article-title":"Autoimmune hepatitis triggered by administration of an herbal medicine","volume":"92","author":"Kamiyama","year":"1997","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.cgh.2006.10.014_bib78","first-page":"641","article-title":"Autoimmune hepatitis with drug-induced pneumonia due to Sho-saiko-to","volume":"37","author":"Katou","year":"1999","journal-title":"Nihon Kokyuki Gakkai Zasshi"},{"key":"10.1016\/j.cgh.2006.10.014_bib79","doi-asserted-by":"crossref","first-page":"1845","DOI":"10.1007\/BF02212712","article-title":"Liver injuries induced by herbal medicine, sho-saiko-to (xiao-chai-hu-tang)","volume":"40","author":"Itoh","year":"1995","journal-title":"Dig Dis Sci"},{"key":"10.1016\/j.cgh.2006.10.014_bib80","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1046\/j.1365-2362.1997.2020749.x","article-title":"Phyllanthus amarus suppresses hepatitis B virus by interrupting interactions between HBV enhancer I and cellular transcription factors","volume":"27","author":"Ott","year":"1997","journal-title":"Eur J Clin Invest"},{"key":"10.1016\/j.cgh.2006.10.014_bib81","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/0166-3542(93)90019-F","article-title":"Effect of an extract from Phyllanthus amarus on hepatitis B surface antigen gene expression in human hepatoma cells","volume":"20","author":"Yeh","year":"1993","journal-title":"Antiviral Res"},{"key":"10.1016\/j.cgh.2006.10.014_bib82","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1016\/S0140-6736(88)92416-6","article-title":"Effect of Phyllanthus amarus on chronic carriers of hepatitis B virus","volume":"2","author":"Thyagajaran","year":"1988","journal-title":"Lancet"},{"key":"10.1016\/j.cgh.2006.10.014_bib83","doi-asserted-by":"crossref","first-page":"1600","DOI":"10.1016\/0140-6736(90)91436-E","article-title":"Failure of Phyllanthus amarus to eradicate hepatitis B surface antigen form symptomless carriers","volume":"335","author":"Leelarasamee","year":"1990","journal-title":"Lancet"},{"key":"10.1016\/j.cgh.2006.10.014_bib84","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1046\/j.1365-2893.2001.00307.x","article-title":"Genus Phyllanthus for chronic hepatitis B virus infection: a systematic review","volume":"8","author":"Liu","year":"2001","journal-title":"J Viral Hepat"},{"key":"10.1016\/j.cgh.2006.10.014_bib85","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1016\/0168-8278(91)90850-B","article-title":"Beneficial effects of Phyllanthus amarus for chronic hepatitis B, not confirmed","volume":"12","author":"Berk","year":"1991","journal-title":"J Hepatol"},{"key":"10.1016\/j.cgh.2006.10.014_bib86","first-page":"381","article-title":"Efficacy of Phyllanthus amarus for eradication of hepatitis B virus in chronic carriers","volume":"74","author":"Thamlikitkul","year":"1991","journal-title":"J Med Assoc Thai"},{"key":"10.1016\/j.cgh.2006.10.014_bib87","first-page":"243","article-title":"Failure of New Zealand hepatitis B carriers to respond to Phyllanthus amarus","volume":"107","author":"Milne","year":"1994","journal-title":"N Z Med J"},{"key":"10.1016\/j.cgh.2006.10.014_bib88","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1046\/j.1365-2036.2003.01671.x","article-title":"Double-blinded placebo-controlled study of Phyllanthus urinaris for the treatment of chronic hepatitis B","volume":"18","author":"Chan","year":"2003","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.cgh.2006.10.014_bib89","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1136\/bmj.313.7052.253","article-title":"St John\u2019s wort for depression\u2014an overview and meta-analysis of randomised clinical trials","volume":"313","author":"Linde","year":"1996","journal-title":"BMJ"},{"key":"10.1016\/j.cgh.2006.10.014_bib90","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1016\/S0165-6147(00)01716-8","article-title":"St. John\u2019s wort: Prozac form the plant kingdom","volume":"22","author":"Di Carlo","year":"2001","journal-title":"Trends Pharmacol Sci"},{"key":"10.1016\/j.cgh.2006.10.014_bib91","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1128\/AAC.45.2.517-524.2001","article-title":"Pharmacokinetics, safety, and antiviral effects of hypericin, a derivative of St. John\u2019s wort plant, in patients with chronic hepatitis C virus infection","volume":"45","author":"Jacobson","year":"2001","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.cgh.2006.10.014_bib92","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1592\/phco.20.6.568.35152","article-title":"Consumer use of St John\u2019s wort: a survey on effectiveness, safety, and tolerability","volume":"20","author":"Beckmann","year":"2000","journal-title":"Pharmacotherapy"},{"key":"10.1016\/j.cgh.2006.10.014_bib93","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/S0022-3565(24)39043-3","article-title":"Inhibition of human cytochrome P450 enzyme by constituents of St John\u2019s wort, an herbal preparation used in the treatment of depression","volume":"294","author":"Obach","year":"2000","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.cgh.2006.10.014_bib94","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1016\/S0168-8278(00)80321-9","article-title":"Interaction of Hypericum perforatum (St John\u2019s wort) with cyclosporin A metabolism in a patient after liver transplantation","volume":"33","author":"Karliova","year":"2000","journal-title":"J Hepatol"},{"key":"10.1016\/j.cgh.2006.10.014_bib95","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1016\/S0140-6736(99)05467-7","article-title":"Acute heart transplant rejection due to Saint John\u2019s wort","volume":"355","author":"Ruschitkza","year":"2000","journal-title":"Lancet"},{"key":"10.1016\/j.cgh.2006.10.014_bib96","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1345\/aph.10088","article-title":"Drug interaction between St John\u2019s wort and cyclosporine","volume":"34","author":"Barone","year":"2000","journal-title":"Ann Pharmacother"},{"key":"10.1016\/j.cgh.2006.10.014_bib97","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1002\/(SICI)1099-1573(199705)11:3<189::AID-PTR67>3.0.CO;2-R","article-title":"Antiviral activities of aucubin against hepatitis B virus replication","volume":"11","author":"Chang","year":"1997","journal-title":"Phytother Res"},{"key":"10.1016\/j.cgh.2006.10.014_bib98","unstructured":"Chang I-M. Antiviral activity of aucubin derived from traditional Chinese herbs in HepG2, woodchucks and humans infected with hepatitis B (abstr). Comp Alternative Med Chronic Liver Dis p. 5."},{"key":"10.1016\/j.cgh.2006.10.014_bib99","first-page":"4","article-title":"Long-term follow up results of compound Dan Shen granule (861 Chong Fu Ji) in treating hepatofibrosis","volume":"5","author":"Wang","year":"1995","journal-title":"Chin J Integr Trad West Med"},{"key":"10.1016\/j.cgh.2006.10.014_bib100","first-page":"214","article-title":"The effect of herbal compound 861 on mRNA levels for type I, III and IV collagens and TGF in immune complex rat liver fibrosis","volume":"4","author":"Jia","year":"1996","journal-title":"Chin J Hepatol"},{"key":"10.1016\/j.cgh.2006.10.014_bib101","first-page":"78","article-title":"Proliferation and apoptosis of hepatic stellate cells and effects of compound 861 on liver fibrosis","volume":"8","author":"You","year":"2000","journal-title":"Chung Hua Kan Tsang Ping Tsa Chih"},{"key":"10.1016\/j.cgh.2006.10.014_bib102","doi-asserted-by":"crossref","first-page":"E67","DOI":"10.1046\/j.1440-1746.2000.02100.x","article-title":"Treatment of chronic liver disease with traditional Chinese medicine","volume":"15","author":"Wang","year":"2000","journal-title":"J Gastroenterol Hepatol"},{"key":"10.1016\/j.cgh.2006.10.014_bib103","first-page":"852","article-title":"Effects of CH-100, a Chinese herbal medicine, on acute concanavalin A\u2013mediated hepatitis in control and alcohol-fed rats","volume":"24","author":"Batey","year":"2000","journal-title":"Alcohol Clin Exp Res"},{"key":"10.1016\/j.cgh.2006.10.014_bib104","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1111\/j.1440-1746.1998.01550.x","article-title":"Preliminary report of a randomised, double-blind placebo-controlled trial of a Chinese herbal medicine preparation CH-100 in the treatment of chronic hepatitis C","volume":"13","author":"Batey","year":"1998","journal-title":"J Gastroenterol Hepatol"},{"issue":"Suppl 1","key":"10.1016\/j.cgh.2006.10.014_bib105","first-page":"A384","article-title":"A randomised double blind placebo controlled trial of a Chinese herbal preparation CH-100 in chronic hepatitis C (abstr)","volume":"120","author":"Mollison","year":"2001","journal-title":"Hepatology"},{"issue":"Suppl 1","key":"10.1016\/j.cgh.2006.10.014_bib106","first-page":"A382","article-title":"A trial of Chinese herbal medicine for chronic hepatitis C (abstr)","volume":"120","author":"Sladden","year":"2001","journal-title":"Hepatology"},{"key":"10.1016\/j.cgh.2006.10.014_bib107","first-page":"694","article-title":"Hepatoprotective effect of LIV. 52 against CCL4 induced lipid peroxidation in the liver of rats","volume":"32","author":"Pandey","year":"1994","journal-title":"Ind J Exp Biol"},{"key":"10.1016\/j.cgh.2006.10.014_bib108","first-page":"762","article-title":"Hepatoprotective effects of Liv.52 on ethanol induced liver damage in rats","volume":"37","author":"Sandhir","year":"1999","journal-title":"Ind J Exp Biol"},{"key":"10.1016\/j.cgh.2006.10.014_bib109","first-page":"738","article-title":"Efficacy of an indigenous compound preparation (LIV.52) in acute viral hepatitis-a double blind study","volume":"64","author":"Sama","year":"1976","journal-title":"Ind J Med Res"},{"issue":"Suppl 1","key":"10.1016\/j.cgh.2006.10.014_bib110","first-page":"127","article-title":"The ayurvedic drug LIV.52 in patients with alcoholic cirrhosis","volume":"26","author":"Fleig","year":"1997","journal-title":"J Hepatol"},{"key":"10.1016\/j.cgh.2006.10.014_bib111","first-page":"G125","article-title":"S-adenosylmethionine (adomet) deficiency and tumor necrosis factor (TNF) in lipopolysaccharide (LPS) induced hepatic injury","volume":"275","author":"Chawla","year":"1998","journal-title":"Am J Physiol"},{"key":"10.1016\/j.cgh.2006.10.014_bib112","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1177\/014860719902300101","article-title":"Treatment with glutathione precursor decreases cytokine activity","volume":"23","author":"Pena","year":"1999","journal-title":"J Parental Enternal Nutr"},{"key":"10.1016\/j.cgh.2006.10.014_bib113","doi-asserted-by":"crossref","first-page":"2334","DOI":"10.1093\/jn\/128.12.2334","article-title":"Green tea polyphenols block endotoxin-induced tumor necrosis factor- production and lethality in a murine model","volume":"128","author":"Yang","year":"1998","journal-title":"J Nutr"},{"key":"10.1016\/j.cgh.2006.10.014_bib114","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1016\/S0168-8278(99)80263-3","article-title":"S-adenosylmethionine in alcoholic liver cirrhosis: a randomized, placebo-controlled, double-blind, multicenter clinical trial","volume":"30","author":"Mato","year":"1999","journal-title":"J Hepatol"},{"key":"10.1016\/j.cgh.2006.10.014_bib115","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD002235.pub2","article-title":"S-adenosyl-L-methionine for alcoholic liver diseases","volume":"2","author":"Rambaldi","year":"2006","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.cgh.2006.10.014_bib116","doi-asserted-by":"crossref","first-page":"1498","DOI":"10.1136\/bmj.292.6534.1498","article-title":"Complementary medicine and the general practitioner","volume":"292","author":"Wharton","year":"1986","journal-title":"BMJ"},{"key":"10.1016\/j.cgh.2006.10.014_bib117","first-page":"268","article-title":"Effects of acupuncture on the immunological functions in hepatitis B virus carriers","volume":"19","author":"Chen","year":"1999","journal-title":"J Tradit Chin Med"},{"key":"10.1016\/j.cgh.2006.10.014_bib118","first-page":"289","article-title":"Combined traditional Chinese medicine and western medicine","volume":"107","author":"Li","year":"1994","journal-title":"Chin Med J"},{"key":"10.1016\/j.cgh.2006.10.014_bib119","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1093\/oxfordjournals.aje.a114834","article-title":"A large outbreak of acupuncture associated hepatitis B","volume":"127","author":"Kent","year":"1988","journal-title":"Am J Epidemiol"},{"issue":"Suppl 1","key":"10.1016\/j.cgh.2006.10.014_bib120","first-page":"E91","article-title":"Transmission of hepatitis C virus in Asia: past and present perspectives","volume":"15","author":"Kao","year":"2000","journal-title":"J Gastroenterol Hepatol"},{"key":"10.1016\/j.cgh.2006.10.014_bib121","doi-asserted-by":"crossref","first-page":"342","DOI":"10.2165\/00002018-199717050-00006","article-title":"Traditional remedies and food supplements","volume":"17","author":"Shaw","year":"1997","journal-title":"Drug Saf"},{"key":"10.1016\/j.cgh.2006.10.014_bib122","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1001\/jama.282.1.28","article-title":"Liver enzyme elevation in patients treated with traditional Chinese medicine","volume":"282","author":"Melchart","year":"1999","journal-title":"JAMA"},{"key":"10.1016\/j.cgh.2006.10.014_bib123","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1007\/s11894-999-0087-2","article-title":"Is there any use for non-traditional or alternative therapies in patients with chronic liver disease?","volume":"1","author":"Bass","year":"1999","journal-title":"Curr Gastroenterol Rep"},{"key":"10.1016\/j.cgh.2006.10.014_bib124","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1016\/S1089-3261(05)70029-5","article-title":"Liver injury from herbs and other botanicals","volume":"2","author":"Schiano","year":"1998","journal-title":"Clin Liver Dis"},{"key":"10.1016\/j.cgh.2006.10.014_bib125","series-title":"Hepatitis C","first-page":"427","article-title":"Complementary and alternative medicine in hepatitis C","author":"Strader","year":"2000"},{"key":"10.1016\/j.cgh.2006.10.014_bib126","doi-asserted-by":"crossref","first-page":"1050","DOI":"10.1016\/S0016-5085(85)80027-5","article-title":"Hepatic venocclusive disease associated with the consumption of pyrrolizidine-containing dietary supplements","volume":"88","author":"Ridker","year":"1985","journal-title":"Gastroenterology"},{"key":"10.1016\/j.cgh.2006.10.014_bib127","doi-asserted-by":"crossref","first-page":"129","DOI":"10.7326\/0003-4819-117-2-129","article-title":"Hepatitis after Germander (Teucrium chanaedrys) administration: another instance of herbal medicine hepatotoxicity","volume":"117","author":"Larrey","year":"1992","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.cgh.2006.10.014_bib128","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1136\/gut.36.1.146","article-title":"Hepatitis induced by traditional Chinese herbs, possible toxic components","volume":"36","author":"Kane","year":"1995","journal-title":"Gut"},{"key":"10.1016\/j.cgh.2006.10.014_bib129","doi-asserted-by":"crossref","first-page":"2200","DOI":"10.1001\/archinte.158.20.2200","article-title":"Herb medicinals: selected clinical considerations focusing on known or potential drug-herb interactions","volume":"158","author":"Miller","year":"1998","journal-title":"Arch Intern Med"}],"container-title":["Clinical Gastroenterology and Hepatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1542356506010524?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1542356506010524?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T04:59:06Z","timestamp":1761541146000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1542356506010524"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,4]]},"references-count":129,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2007,4]]}},"alternative-id":["S1542356506010524"],"URL":"https:\/\/doi.org\/10.1016\/j.cgh.2006.10.014","relation":{},"ISSN":["1542-3565"],"issn-type":[{"value":"1542-3565","type":"print"}],"subject":[],"published":{"date-parts":[[2007,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Complementary and Alternative Medicine in Hepatology: Review of the Evidence of Efficacy","name":"articletitle","label":"Article Title"},{"value":"Clinical Gastroenterology and Hepatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cgh.2006.10.014","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2007 AGA Institute. Published by Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}